Cardiologia
Revisão sobre as complicações vasculares na COVID-19.
2 Nov, 2021 | 12:34hEstudo de coorte | Entre pacientes com infarto do miocárdio com elevação do segmento ST, o diagnóstico concomitante de Covid-19 está associado a aumento de mortalidade intra-hospitalar.
1 Nov, 2021 | 11:01hEditorial: Myocardial Infarction During the COVID-19 Pandemic – JAMA
Comentário: STEMI and COVID-19 Often a Lethal Combo, Affirms Largest Study Yet – TCTMD
Comentário do autor no Twitter (fio – clique para saber mais)
1/8 It was not unexpected that pts w/ #STEMI would fare worse w/ than w/o #COVID19 https://t.co/B7oWnJunEa
— Herb Aronow, MD, MPH (he/him/his) (@herbaronowMD) October 29, 2021
Estudo randomizado | Buscar níveis mais altos de pressão arterial intraoperatória não reduz os eventos adversos cardiovasculares após cirurgia não cardíaca.
1 Nov, 2021 | 10:55hEstudo sugere que interromper, e não apenas diminuir, o tabagismo está associado com redução no risco de doença cardiovascular.
1 Nov, 2021 | 10:54hSmoking cessation, but not reduction, reduces cardiovascular disease incidence – European Heart Journal (link para o resumo – $ para o texto completo)
Comentário no Twitter
May I just reduce the number of cigarettes? New study shows this is not enough! Smoking cessation, but not reduction, was associated with cardiovascular disease incidence drop.https://t.co/lVgXMwavNs#smoke, #cigarettes, #MI, #cardiotwitter, @ESC_Journals, @escardio. pic.twitter.com/FrqB5V2tx3
— EHJ Editor-in-Chief (@ehj_ed) October 31, 2021
Exame clínico cardiovascular: a necessidade de uma abordagem baseada em evidências.
1 Nov, 2021 | 10:52h
Comentário no Twitter
Which role for cardiac clinical examination today?
According to new cardiopulse, cardiac physical diagnosis shold be regarded as a science that can be learnt, rather than an art that can only be aspired to.https://t.co/oG1NJusXrS#cardiotwitter, @ESC_Journals, @escardio. pic.twitter.com/B9iUSv0gnj— EHJ Editor-in-Chief (@ehj_ed) October 30, 2021
Diretriz AHA/ACC 2021 para avaliação e diagnóstico de dor torácica.
29 Out, 2021 | 14:49hResumo executivo: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain – Journal of the American College of Cardiology
Comunicado de imprensa: First-Ever Guideline Focused Solely on Chest Pain Evaluation, Diagnosis Released
Foco da diretriz: Guideline for the Evaluation and Diagnosis of Chest Pain
Pontos principais: 2021 AHA/ACC Chest Pain Guideline – American College of Cardiology
Comentário: New Chest Pain Guidelines Out at Last: Most Tests Have a Role – TCTMD
Comentário no Twitter (fio – clique para saber mais)
The Chest Pain Guidelines are now released!https://t.co/xQxCWzReEN
Top 10: CHEST PAINS
Thanks to the entire writing group and my co-cahirs: Deb Murkerjee & Phil Levy
💥First Chest Pain Guidelines @AHAScience @ACCinTouch pic.twitter.com/s17piamrKR— Dr. Martha Gulati “Get Vaccinated Please” (@DrMarthaGulati) October 28, 2021
Revisão sistemática | Agonistas receptores de GLP-1 e inibidores de SGLT-2 parecem reduzir o risco de morte por doença cardiovascular e morte por qualquer causa em pessoas com diabetes e doença cardiovascular estabelecida.
29 Out, 2021 | 14:44h
Comentário no Twitter
The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease https://t.co/0FwffSCqbC New @CochraneHeart network meta-analysis looks at evidence from 31 studies. #CardiovascularResearch
— The Cochrane Library (@CochraneLibrary) October 27, 2021
Revisão sistemática | Não há evidências suficientes informando sobre a decisão de interromper ou continuar a anticoagulação antes da ablação por cateter em pacientes com arritmia.
29 Out, 2021 | 14:37hLesão cerebral após parada cardíaca: fisiopatologia, tratamento e prognóstico.
29 Out, 2021 | 14:35h
Comentário no Twitter
Post-cardiac arrest brain injury, narrative review:
🧠pathophysiology: primary (ischemic) & secondary (reperfusion)
🧠treatment options
🧠outcomes
🧠neuroprognostication
🧠@ERC_resus @ESICM 2021 algorithm for prognostication
Open #FOAMcc #FOAMres @yourICM https://t.co/b8GRhE3MuF pic.twitter.com/q10DJVRJOp— Intens Care Med (@yourICM) October 27, 2021
Prescrição de estimulantes está associada a aumento dos riscos de curto prazo de eventos cardiovasculares em idosos.
29 Out, 2021 | 14:34hAssessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults – JAMA Network Open
Comentários:
Stimulants Linked to Early Risk of CV Events in Elderly – TCTMD
Stimulants May Pose Short-Term Cardiovascular Risks in Older Adults – Psychiatric News Alert